Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Niagen Bioscience, Inc. (NAGE) had Revenue of $99.60M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$99.60M
Net Income	$8.55M
Cost of Goods Sold	$38.01M
Gross Profit	$61.59M
Operating Expenses	$91.87M
Operating Income	$7.73M
Non-Operating Income/Expense	$1.13M
Pre-Tax Income	$8.86M
Normalized Pre-Tax Income	$8.86M
Income after Taxes	$8.55M
Income from Continuous Operations	$8.55M
Consolidated Net Income/Loss	$8.55M
Normalized Income after Taxes	$8.55M
EBIT	$7.73M
EBITDA	$8.54M
Weighted-Average Shares Outstanding (Basic)	75.93M
Weighted-Average Shares Outstanding (Diluted)	78.12M
Earnings per Share (EPS) (Basic)	$0.11
Earnings per Share (EPS) (Diluted)	$0.11
Balance Sheet Financials
Current Assets	$64.10M
Property, Plant, and Equipment	$1.72M
Long-Term Assets	$4.18M
Total Assets	$68.28M
Current Liabilities	$17.95M
Long-Term Debt	--
Long-Term Liabilities	$4.24M
Total Liabilities	$22.18M
Common Equity	$46.09M
Tangible Shareholders Equity	$45.73M
Shareholders Equity	$46.09M
Common Shares Outstanding	77.33M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$12.11M
Cash Flow from Investing Activities	$-0.14M
Cash Flow from Financial Activities	$5.37M
Beginning Cash	$27.32M
End Cash	$44.66M
Increase/Decrease in Cash	$17.34M
Stock-Based Compensation	$3.66M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.57
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.00
Gross Margin	61.84%
Operating Margin	7.76%
EBIT Margin	7.76%
EBITDA Margin	8.57%
Pre-Tax Profit Margin	8.89%
Profit Margin	8.58%
Free Cash Flow	$11.97M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.46
Inventory Turnover	4.14
Receiveable Turnover	12.82
Days Sales in Receivables	28.47
Return on Equity	18.55%
Return on Tangible Equity	18.69%
Return on Assets	12.52%
Return on Investments	18.55%
Book Value Per Share	$0.60
Free Cash Flow per Share	$0.15
Operating Cash Flow per Share	$0.15

Data from Zacks Investment Research, Inc.